DC BioFuture

Tuesday, October 5th – Friday, October 8th

Digital Event:
Click here for access

 Overview:

Join Outcome Capital’s Managing Director,     Dr. Paul Mieyal to explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more.

For more information, please contact pmieyal@outcomecapital.com
Resources

A Shifting Market Environment and Strategies Fueling Innovation in Prostate Cancer Treatment

Blockbuster drug patent expiration, advances in enabling technology, and the emergence of personalized medicine for prostate cancer treatment create a landscape worth examining.

Download
Resources

Outcome Capital Life Science Market Pulse, March 2025

Outcome Capital Life Science Market Pulse March 2025 Click to view our LifeSciences Pulse Newsletter

Download

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278

© Outcome Capital 2025. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC

Business Continuity Plan | Privacy Policy | Regulation Best Interest

Built by Metropolis